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that had at least five attacks fulfilling criteria for migraine with/or without aura. This disorder 
affects 1,4-2,2% of the population and is associated with a higher headache impact in 
comparison with the episodic migraine. Medication overuse of acute analgesics often occurs 
with chronic migraine. In patients with migraine frequent intake of acute headache medication 
can increase the frequency and intensity of headache, causing a vicious circle of further intake 
of medication and increased attack frequency. Here is how the treatment can become the cause 
of another separate condition, known as medication-overuse headache.  
Aim of the study. To determine medication overuse of acute treatment in patients with chronic 
migraine and its impact to the severity of the disease.  
Materials and methods. In this study were included 36 patients with confirmed clinical 
diagnosis of chronic migraine who requested a consultation of a neurologist at the Institute of 
Neurology and Neurosurgery in Chisinau. The study was based on survey: self-report 
questionnaire with references to the medicamentous migraine treatment and Migraine patient 
assessment questionnaire from the National Clinical Protocol. A clinical analysis of the disease 
and medication intake were performed. The patients were separated in two groups: with and 
without medication overuse of acute treatment (medication overuse is diagnosed if a limit 
medication days per month is exceeded for ergotamines, triptans, opioids and combination 
drugs ≥10 days per month, and for simple analgesics ≥15 days per month, both for longer than 
3 months), based on the results of two questionnaires. Student-T test was chosen as statistical 
criteria for this research.  
Results. We found that patients with medication overuse of acute treatment have a significantly 
more severe clinical signs of the disease. We compared the following clinical outcomes: 
number of days with headache per month and intensity of headache. In case of medication 
abuse we found higher values on two parameters: frequency (p<0.0001) and intensity 
(p=0.0016) of headache per month.   
Conclusions. On conclusion, the analysis of our data support the concept that medication 
overuse is the reason for the development of more severe clinical signs in patients with existing 
primary headache disorder. Patients who managed correctly their migraine attacks have 
moderated clinical signs.  
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Introduction. Numerous recent studies show that misuse of stimulants by individuals without 
ADHD (Attention Deficit Hyperactivity Disorder) has increased over last years, in order to 
enhance cognitive performance. This is especially popular among students. Hence, the need to 
assess the effects of methylphenidate on healthy brain (without ADHD), as well as the 
associated adverse reactions, arises.  
Aim of the study. To evaluate the prevalence of methylphenidate (MPH) usage among medical 
students, to emphasize pharmacological effects and adverse reactions.  
Materials and methods. A self-administered, anonymous questionnaire was distributed in 
online and sheet forms to students of the ungraduated medical programme. The literature 
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review on stimulants misuse has been performed, including search of following databases: 
PubMed, ResearchGate, neurology.com, etc.  
Results. 114 questionnaires have been completed, including: 34 – online and 80 – on sheets. 
Approximately 14,0% (16 of 114) of surveyed students have used MPH for non-medical 
purposes. Most of them used it to enhance their ability to concentrate 63,64 % (7 of 11). Next 
adverse reactions were mentioned: tachycardia/High Blood Pressure (8 of 13); anxiety/fear (5 
of 13); headache (5 of 13); seizures/convulsions (2 of 13); sleep disorders (9 of 14).  Recent 
studies put college students’ nonprescription use of stimulant drugs — Ritalin and 
amphetamines such as Adderall and Dexedrine — at rates anywhere between 14 and 38 
percent, depending on the type of college and age of student. Main purpose of usage is 
enhancing the ability to concentrate and memorize. Most frequent adverse reactions (>10%) 
are: psychiatric disorders, insomnia, irritability, decreased appetite, headache, infections.  
Conclusions. The prevalence of MPH usage among medical students fits in general statistics. 
The primary reason of usage also coincides. Some respondents have not mentioned the 
emergence or absence of adverse reactions. This may be due to refusal to answer or 
unawareness of the adverse reactions. The literature review revealed that benefic effects of 
MPH are observed in individuals with lower ability of concentration/memorization, showing 
that the drug is more effective at correcting deficits than “enhancing performance”. In 
individuals with good ability of concentration/memorization enhanced motivation has been 
observed, although associated with higher incidence of adverse reactions.  
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Introduction. Paracetamol and the combined drugs, which belong to the OTC list that are 
released without a prescription, are most commonly used in the symptomatic treatment or self-
treatment of acute respiratory infections. The diversity of trade names often misleads patients 
who resort to their administration without consulting a doctor. For these reasons, there is an 
increase in the incidence of acute intoxication and fatal adverse reactions (fulminant hepatic 
necrosis, etc.).  
Aim of the study. The aim of the study consisted in analyzing the presence on the 
pharmaceutical market of mono- and combined drugs containing paracetamol and estimating 
possible risk of side effects in self-treatment with them.  
Materials and methods. Based on the study of the State Drug Nomenclature, were selected 
drugs containing paracetamol with analysis of single dose and combination diversity.  
Results. In the Republic of Moldova there are 95 mono- or combined drugs containing 
paracetamol (acetaminophen), including producers from: Moldova - 22, Romania - 20, Ukraine 
13, Belarus - 12, Turcia - 5, Russia - 5, Slovenia - 6, Georgia - 4, India - 4, Bosnia and 
Herzegovina - 2, United Kingdom -1, Germany - 1. The presence of single-dose mono drugs 
containing paracetamol of 50-250 mg for children and 500-600 mg for adults was found. There 
is a wide range of combined drugs including: paracetamol + decongestant adrenomimetics 
(phenylephrine, pseudoephedrine), paracetamol + H1-antihistamines (pheniramine, 
